DOXEPIN HYDROCHLORIDE
NDC 69315-160, DOXEPIN HYDROCHLORIDE, capsule, from Leading Pharma, LLC.
- Product NDC
- 69315-160
- Status
- Listed
- Labeler
- Leading Pharma, LLC
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA211619
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/69315-160 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DOXEPIN HYDROCHLORIDE50 mg/1
Pharmacologic classes
Tricyclic Antidepressant [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69315-160-01 | 69315016001 | 100 CAPSULE in 1 PACKAGE (69315-160-01) |
| 69315-160-10 | 69315016010 | 1000 CAPSULE in 1 PACKAGE (69315-160-10) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/e6a4cb10-1928-4abe-8797-404c9ddc37dd
Use it
Look up 69315-160 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69315-160 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69315-160. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.